Home › Funds › PFM Health Sciences, LP › EW

PFM Health Sciences, LP position in EW

EDWARDS LIFESCIENCES CORP · Health Care

PFM Health Sciences, LP reported holding 250,453 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q2 2026 13F filing — a position valued at US$22.7M, representing 1.98% of its reported portfolio and ranking #13 among its reported holdings. PFM Health Sciences, LP has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)250.45K sh
Reported value held$22.66M
Portfolio Weight1.98%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's EW position evolved

PFM Health Sciences, LP first disclosed a stake in EW in Q3 2023 at 702,588 shares (US$48.7M). The position peaked in Q1 2024 at 740,260 shares, worth US$70.7M. Across 12 filings, PFM Health Sciences, LP increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 250,453 shares valued at US$22.7M — a reduction of -4,057 shares quarter over quarter.. Notable position changes include a 47% trim in Q3 2024 (shares rose 12% over the following quarter), a 34% increase in Q4 2024 (shares fell 2% over the following quarter), a 35% trim in Q4 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 702.59K $48.68M New
Q4 2023 740.26K $56.44M Add
Q1 2024 740.26K $70.74M Hold
Q2 2024 740.26K $68.38M Hold
Q3 2024 390.86K $25.79M Reduce
Q4 2024 525.40K $38.90M Add
Q1 2025 379.95K $27.54M Reduce
Q2 2025 392.50K $30.70M Add
Q3 2025 381.32K $29.66M Reduce
Q4 2025 246.84K $21.04M Reduce
Q1 2026 254.51K $20.38M Add
Q2 2026 250.45K $22.66M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 34 other funds we track also report a position in EW — the largest reported positions include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B), Aristotle Capital Management, LLC (US$783.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has PFM Health Sciences, LP held EW?

PFM Health Sciences, LP has disclosed EW holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is PFM Health Sciences, LP's current position in EW?

As of Q2 2026, PFM Health Sciences, LP holds 250.45K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $22.66M, representing 1.98% of its reported portfolio and ranking #13.

Has PFM Health Sciences, LP been buying or selling EW?

In the latest 13F filing (Q2 2026), PFM Health Sciences, LP reduced its position in EW. The position peaked in Q1 2024 at 740.26K shares.

Which other funds hold EW?

Other major institutional holders of EW include DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, Aristotle Capital Management, LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.